As of April 1, 2026, Tonix Pharmaceuticals Holding Corp. (TNXP) trades at $13.68, marking a 0.51% decline in the latest trading session. This analysis explores key technical levels, recent market context for the biopharmaceutical stock, and potential near-term price scenarios based on current trading patterns. No recent earnings data is available for TNXP as of this writing, so price action is currently driven primarily by sector sentiment and technical flows rather than quarterly fundamental pe
TNXP Stock Analysis: Tonix Pharmaceuticals Holding Corp dips 0.51 pct to 13.68
TNXP - Stock Analysis
4063 Comments
1844 Likes
1
Montario
New Visitor
2 hours ago
Great way to get a quick grasp on current trends.
👍 282
Reply
2
Kazimer
Power User
5 hours ago
Missed out again… sigh.
👍 158
Reply
3
Averyl
Engaged Reader
1 day ago
This feels like something I shouldn’t know.
👍 105
Reply
4
Kilbourne
Registered User
1 day ago
This would’ve given me more confidence earlier.
👍 124
Reply
5
Careese
Influential Reader
2 days ago
Real-time US stock guidance and management outlook analysis to understand forward expectations and sentiment for better earnings anticipation. Our earnings call analysis extracts the key takeaways and sentiment signals that often move stock prices significantly after reported results. We provide guidance analysis, sentiment scoring, and management outlook reviews for comprehensive coverage. Understand forward expectations with our comprehensive guidance analysis and sentiment tools for earnings trading.
👍 271
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.